Naar inhoud
Rijksinstituut voor Volksgezondheid en Milieu

Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses | RIVM

Jaar: 2022
Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses | RIVM